Haegarda drug purchase for VA GLA HCS pharmacy
Ended Awarded Last action
- Contract number
- 36C26222N0328
- Awardee
-
CSL Behring L.L.C. UEI H3WKVE9VBLY3
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $87,957
Award facts
- Contract value 100% obligated
- $87,956.80 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- King of Prussia, PA 19406, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the procurement of the drug HAEGARDA by the Veterans Affairs Greater Los Angeles Healthcare System (VA GLA HCS) Pharmacy. The contract was awarded to CSL Behring L.L.C., a global biotherapeutics company specializing in plasma-derived and recombinant therapies, for a ceiling value of $87,956.80. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type, and has an ultimate completion date of March 21, 2022. The contract is not set aside and is associated with CSL Behring's existing Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) with the Department of Veterans Affairs, which has a ceiling value of $201,482,280 and is valid through September 2026. This award supports the VA's healthcare programs for veterans by enabling the efficient procurement of critical medications through pre-negotiated pricing and terms.
Quick answers
Who was awarded contract 36C26222N0328?
36C26222N0328 was awarded to CSL Behring L.L.C. by Veterans Integrated Service Network 22 (Veterans Health Administration) on February 21, 2022.
How much is contract 36C26222N0328 worth?
The government has obligated $87,957 on 36C26222N0328.
Is contract 36C26222N0328 an order under another contract?
Yes. 36C26222N0328 is a BPA call under 36F79721D0249-36E79721A0024, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26222N0328 competed?
The extent of competition for 36C26222N0328 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award